Comparing Ioband® waterproof dressing to standard dressing after knee surgery
Does Ioband Coverage Waterproof Dressing Provide Better Outcome Than Isolate Waterproof Dressing After Primary Total Knee Arthroplasty? A Prospective Randomized Controlled Trial
NA · Thammasat University Hospital · NCT06943053
This study is testing whether a new waterproof dressing called Ioband® works better than a standard dressing for people recovering from knee surgery by seeing if it needs to be changed less often and if patients are happier with it.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | Thammasat University Hospital (other) |
| Locations | 2 sites (Pathum Thani, Khlong luang and 1 other locations) |
| Trial ID | NCT06943053 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Ioband® coverage waterproof dressing compared to standard waterproof dressing in patients who have undergone total knee arthroplasty (TKA). It aims to determine if the Ioband® dressing reduces the frequency of dressing changes and the degree of peel-off, as well as to assess overall patient satisfaction. Participants will be randomly assigned to receive either dressing type, and their outcomes will be monitored post-operatively. The study involves 96 patients and utilizes a randomized controlled design.
Who should consider this trial
Good fit: Ideal candidates are patients aged 55-80 who are undergoing primary unilateral total knee arthroplasty.
Not a fit: Patients with chronic skin diseases, chronic steroid use, or allergies to skin adhesives may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved wound care management and patient satisfaction after total knee arthroplasty.
How similar studies have performed: Similar studies have shown promising results in improving post-operative care with advanced dressing techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary unilateral TKA * Age 55-80 yrs Exclusion Criteria: * Chronic Skin disease such as Psoriasis * Chronic steroid use * Allergy to skin adhesive, Cover wound * Robotic TKA * Iodine allergy * Not follow protocol
Where this trial is running
Pathum Thani, Khlong luang and 1 other locations
- Thammasat University Hospital — Pathum Thani, Khlong luang, Thailand (RECRUITING)
- Department of Orthopaedics, Thammasat University — Pathum Thani, Thailand (RECRUITING)
Study contacts
- Principal investigator: Chanon Thassanaleelaporn, M.D. — Thammasat University Hospital Thailand
- Study coordinator: Krit Boontanapibul, M.D.
- Email: krit.boontanapibul@gmail.com
- Phone: 66613957799
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Postoperative Wound Care After TKA, total knee arthroplasty, Ioband® coverage waterproof dressing